{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:56:37Z","timestamp":1784735797536,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10147-020-01792-w","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T11:04:27Z","timestamp":1601377467000},"page":"163-168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy and safety of low-dose everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8163-0087","authenticated-orcid":false,"given":"Takashi","family":"Hatano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhisa","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Tamari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"1792_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","volume":"372","author":"P Curatolo","year":"2008","unstructured":"Curatolo P, Bombardieri R, Jozwiak S (2008) Tuberous sclerosis. Lancet 372:657\u2013658","journal-title":"Lancet"},{"key":"1792_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M van Slegtenhorst","year":"1997","unstructured":"van Slegtenhorst M, de Hoogt R, Hermans C et al (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805\u2013808","journal-title":"Science"},{"key":"1792_CR3","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","volume":"75","author":"The European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","unstructured":"The European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305\u20131315","journal-title":"Cell"},{"key":"1792_CR4","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/j.juro.2007.07.058","volume":"178","author":"M Castagnetti","year":"2007","unstructured":"Castagnetti M, Vezzu B, Laverda A et al (2007) Urological counseling and follow up in pediatric tuberous sclerosis complex. J Urol 178:2155\u20132159","journal-title":"J Urol"},{"key":"1792_CR5","doi-asserted-by":"publisher","first-page":"e63910","DOI":"10.1371\/journal.pone.0063910","volume":"8","author":"MW Kaneda","year":"2013","unstructured":"Kaneda MW, Tanaka M, Hamasaki T, Katayama I (2013) Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients. PLoS ONE 8:e63910","journal-title":"PLoS ONE"},{"key":"1792_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.diii.2013.01.003","volume":"94","author":"O Rouviere","year":"2013","unstructured":"Rouviere O, Nivet H, Grenier N et al (2013) Kidney damage due to tuberous sclerosis complex: management recommendations. Diagn Interv Imaging 94:225\u2013237","journal-title":"Diagn Interv Imaging"},{"key":"1792_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.juro.2015.07.126","volume":"195","author":"AS Flum","year":"2016","unstructured":"Flum AS, Hamoui N, Said MA et al (2016) Update on the diagnosis and management of renal angiomyolipoma. J Urol 195:834\u2013846","journal-title":"J Urol"},{"key":"1792_CR8","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","volume":"70","author":"SK Rakowski","year":"2006","unstructured":"Rakowski SK, Winterkorn EB, Paul E et al (2006) Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int 70:1777\u20131782","journal-title":"Kidney Int"},{"key":"1792_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","volume":"48","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Northrup H (2013) International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendation of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediat Neurol 48:255\u2013265","journal-title":"Pediat Neurol"},{"key":"1792_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13256-019-2041-8","volume":"13","author":"M Murata","year":"2019","unstructured":"Murata M, Ikeda Y, Hasegawa G et al (2019) Low-dose axitinib rechallenge with positive outcomes in a patient with metastatic renal cell carcinoma refractory to interferon a, sunitinib, and nivolumab therapies: a case report. J Med Case Rep 13:98","journal-title":"J Med Case Rep"},{"key":"1792_CR11","doi-asserted-by":"publisher","first-page":"64089","DOI":"10.18632\/oncotarget.11596","volume":"27","author":"AL Wong","year":"2016","unstructured":"Wong AL, Sunder R, Wang TT et al (2016) Phase lb\/ll randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course subitinib in the pre-operative treatment of breast cancer. Oncotarget 27:64089\u201364099","journal-title":"Oncotarget"},{"key":"1792_CR12","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1007\/s00246-017-1688-4","volume":"38","author":"JS Chang","year":"2017","unstructured":"Chang JS, Chiou PY, Yao SH, Chou IC, Lin CY (2017) Regression of neonatal cardiac rhabdmyoma in two months through low-dose everolimus therapy: a report of three cases. Pediar Cardiol 38:1478\u20131484","journal-title":"Pediar Cardiol"},{"key":"1792_CR13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/jim-2018-000865","volume":"67","author":"CC Wei","year":"2019","unstructured":"Wei CC, Tsai JD, Sheu JN et al (2019) Continuous Low-dose everolimus shrinkage tuberous sclerosis complex-associated renal angiomyolipoma: a 48-month follow-up study. J investing Med 67:686\u2013690","journal-title":"J investing Med"},{"key":"1792_CR14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","volume":"381","author":"JJ Bissler","year":"2013","unstructured":"Bissler JJ, Kingswood JC, Radzikowska E et al (2013) Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicenter, randomized, double-blind, placebo-controlled trial. Lancet 381:817\u2013824","journal-title":"Lancet"},{"key":"1792_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/ndt\/gfv249","volume":"31","author":"JJ Bissler","year":"2016","unstructured":"Bissler JJ, Kingswood JC, Radzikowska E et al (2016) Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized, controlled trial. Nephrol Dial Transpl 31:111\u2013119","journal-title":"Nephrol Dial Transpl"},{"key":"1792_CR16","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.1002\/cncr.25219","volume":"116","author":"RJ Motzer","year":"2010","unstructured":"Motzer RJ, Escudier B, Oudard S et al (2010) Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors. Cancer 116:4256\u20134265","journal-title":"Cancer"},{"key":"1792_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1056\/NEJMoa1009290","volume":"364","author":"JC Yao","year":"2011","unstructured":"Yao JC, Shah MH, Ito T et al (2011) Everolimus for advanced pancreatic neuroendocrine tumors. N Eng J Med 364:514\u2013523","journal-title":"N Eng J Med"},{"key":"1792_CR18","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1634\/theoncologist.2018-0340","volume":"24","author":"VE Jones","year":"2019","unstructured":"Jones VE, McIntyre KJ, Paul D et al (2019) Evaluation of miracle mouthwash plus hydrocortisone versus prednisolone mouth rinses as prophylaxis for everolimus-associated stomatitis: a randomized phase II study. Oncologist 24:1153\u20131158","journal-title":"Oncologist"},{"key":"1792_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1432-2277.2006.00423.x","volume":"20","author":"E Huyghe","year":"2007","unstructured":"Huyghe E, Zairi A, Nohra J et al (2007) Gonadal impact of target of rapamycin inhibitors (sirolimus and everolimus) in male patients: an overview. Transpl Int 20:305\u2013311","journal-title":"Transpl Int"},{"key":"1792_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1046\/j.1600-6135.2003.00279.x","volume":"4","author":"L Fritsche","year":"2004","unstructured":"Fritsche L, Budde K, Dragun D et al (2004) Testosterone concentrations and sirolimus in male renal transplant patients. Am J Transplant 4:130\u2013131","journal-title":"Am J Transplant"},{"key":"1792_CR21","doi-asserted-by":"publisher","first-page":"e45868","DOI":"10.1371\/journal.pone.0045868","volume":"7","author":"M Braun","year":"2012","unstructured":"Braun M, Young J, Reiner CS et al (2012) Low-dose oral sirolimus and the risk of menstrual-cycle disturbances and ovarian cysts: analysis of the randomized controlled SUISSE ADPKD trial. PLoS ONE 7:e45868","journal-title":"PLoS ONE"},{"key":"1792_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1590\/S0100-879X2010007500040","volume":"43","author":"JV Salgado","year":"2010","unstructured":"Salgado JV, Neves FA, Bastos MG et al (2010) Monitoring renal function: measured and estimated glomerular filtration rates \u2013 a review. Braz J Med Biol Res 43:528\u2013536","journal-title":"Braz J Med Biol Res"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01792-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-020-01792-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01792-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T20:46:45Z","timestamp":1632862005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-020-01792-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1792"],"URL":"https:\/\/doi.org\/10.1007\/s10147-020-01792-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-34526\/v1","asserted-by":"object"}]},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"4 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of this article declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}